We are live on ! Find out more
NRD

Nebula Research & Development Portfolio holdings

AUM $1.17B
1-Year Est. Return 15.19%
This Fund
S&P 500
This Quarter Est. Return
+8.94%
1 Year Est. Return
+15.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$332M
AUM Growth
+$142M
Cap. Flow
+$119M
Cap. Flow %
35.99%
Top 10 Hldgs %
4.82%
Holding
913
New
440
Increased
113
Reduced
66
Closed
294

Top Buys

Rank Stock Value
1
HUM icon
Humana
HUM
+$1.7M
2
SLB icon
SLB Ltd
SLB
+$1.68M
3
DAY
Dayforce
DAY
+$1.59M
4
IDA icon
Idacorp
IDA
+$1.58M
5
V icon
Visa
V
+$1.49M

Top Sells

Rank Stock Value
1
INTU icon
Intuit
INTU
+$968K
2
ADM icon
Archer Daniels Midland
ADM
+$967K
3
HCA icon
HCA Healthcare
HCA
+$966K
4
ABT icon
Abbott
ABT
+$966K
5
SPGI icon
S&P Global
SPGI
+$965K

Sector Composition

Rank Sector Weight
1 Technology 18.79%
2 Healthcare 14.71%
3 Industrials 14.47%
4 Consumer Discretionary 11.29%
5 Financials 9.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NCLH icon
551
Norwegian Cruise Line
NCLH
$9.63B
$200K 0.06%
+10,004
New +$160K
FSM icon
552
Fortuna Silver Mines
FSM
$2.54B
$200K 0.06%
+51,899
New +$174K
ARCO icon
553
Arcos Dorados Holdings
ARCO
$1.76B
$196K 0.06%
+15,433
New +$165K
MD icon
554
Pediatrix Medical
MD
$2.18B
$194K 0.06%
+20,898
New +$216K
SABR icon
555
Sabre
SABR
$743M
$194K 0.06%
44,159
-83,683
-65% -$323K
SD icon
556
SandRidge Energy
SD
$491M
$194K 0.06%
14,157
-1,278
-8% -$18.9K
DOMO icon
557
Domo
DOMO
$173M
$192K 0.06%
+18,636
New +$172K
DRVN icon
558
Driven Brands
DRVN
$2.47B
$191K 0.06%
13,365
-6,485
-33% -$80.9K
SIRI icon
559
SiriusXM
SIRI
$10.6B
$188K 0.06%
+3,446
New +$166K
GCMG icon
560
GCM Grosvenor
GCMG
$757M
$182K 0.05%
+20,336
New +$169K
UMH
561
UMH Properties
UMH
$1.34B
$179K 0.05%
11,679
-33,459
-74% -$482K
CYH icon
562
Community Health Systems
CYH
$399M
$179K 0.05%
+57,089
New +$154K
CHPT icon
563
ChargePoint
CHPT
$137M
$178K 0.05%
+3,794
New +$212K
MTRX icon
564
Matrix Service
MTRX
$328M
$174K 0.05%
+17,817
New +$193K
ENTA icon
565
Enanta Pharmaceuticals
ENTA
$364M
$174K 0.05%
+18,468
New +$172K
LILAK icon
566
Liberty Latin America Class C
LILAK
$1.64B
$173K 0.05%
25,962
+9,596
+59% +$62.1K
RMAX icon
567
RE/MAX Holdings
RMAX
$208M
$173K 0.05%
+12,977
New +$142K
ARKO icon
568
ARKO Corp
ARKO
$904M
$171K 0.05%
20,770
-3,659
-15% -$28K
BE icon
569
Bloom Energy
BE
$45B
$169K 0.05%
+11,392
New +$143K
PLUG icon
570
Plug Power
PLUG
$2.76B
$164K 0.05%
+36,441
New +$191K
CLNE icon
571
Clean Energy Fuels
CLNE
$423M
$159K 0.05%
41,479
-21,703
-34% -$79.1K
SBH icon
572
Sally Beauty Holdings
SBH
$1.47B
$159K 0.05%
+11,936
New +$116K
RLAY icon
573
Relay Therapeutics
RLAY
$3.94B
$158K 0.05%
+14,314
New +$121K
HBI
574
DELISTED
Hanesbrands
HBI
$157K 0.05%
35,300
-190,410
-84% -$775K
NTGR icon
575
NETGEAR
NTGR
$670M
$157K 0.05%
+10,787
New +$140K
21 22
23
24 25

Similar funds

SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
HIP
HPS Investment Partners New York $1.52B AUM 19.81% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return

Nebula Research & Development's Q4 2023 Portfolio in Review

As of Q4 2023, Nebula Research & Development held 913 positions worth $332M, up 75% from $190M the previous quarter. Its ten largest holdings account for 4.8% of the portfolio.

Nebula Research & Development deployed $119M of net new capital in Q4 2023, opening 440 new positions and adding to 113 existing holdings. Its largest new stake was Humana: 3,439 shares worth $1.57M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Hanesbrands, an estimated $775K trimmed.

  • Nebula Research & Development's largest Q4 2023 buy was Humana: 3,439 shares worth $1.57M.
  • Nebula Research & Development added most to AppFolio in Q4 2023, an estimated $1.43M increase.
  • Nebula Research & Development's biggest Q4 2023 reduction was Hanesbrands, cutting an estimated $775K.
  • Nebula Research & Development fully exited Intuit in Q4 2023, selling an estimated $968K.
  • Nebula Research & Development's ten largest holdings make up 4.8% of its $332M portfolio in Q4 2023.
  • Nebula Research & Development opened 440 new positions and closed 294 in Q4 2023.
  • Nebula Research & Development's portfolio value rose 75% quarter-over-quarter to $332M.

Based on Nebula Research & Development's 13F filing for Q4 2023, filed 14 Feb 2024.